WO2022160018 - ANTIVIRAL NASAL SPRAY
National phase entry:
Publication Number
WO/2022/160018
Publication Date
04.08.2022
International Application No.
PCT/AU2022/050103
International Filing Date
15.02.2022
Title **
[English]
ANTIVIRAL NASAL SPRAY
[French]
PULVÉRISATION NASALE ANTIVIRALE
Applicants **
MEYERS, Alicia, Gemma, Eileen
15 Birmingham Ave
Villawood
New South Wales
Villawood, New South Wales 2163, AU
MCCAFFREY, Stephen, Mark
17 Araluen Ave
Saint Marys
New South Wales 2670, AU
HAGGART, Ethan Tobias Grey
47B Shanaway Rise
Hillcrest 0627
Auckland, NZ
Inventors
MEYERS, Alicia, Gemma, Eileen
15 Birmingham Ave
Villawood
New South Wales
Villawood, New South Wales 2163, AU
Priority Data
2022200728
03.02.2022
AU
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP Australia
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 953 | |
| EPO | Filing, Examination | 4853 | |
| Japan | Filing | 590 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 3310 |
Total: 10280 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The invention is directed to a nasal spray formulation comprising bee pollen and/or propolis together with Manuka honey UMF 20+, which formulation can be used for preventing coronavirus infection.[French]
L'invention concerne une formulation de pulvérisation nasale comprenant du pollen et/ou de la propolis d'abeille associé à du miel Manuka UMF 20+, ladite formulation pouvant être utilisée pour prévenir une infection à coronavirus.